Stock listing

BSE:EPIGRAL Epigral Ltd Share Price

Indian listing (BSE) of Epigral Ltd · home listing NSE:EPIGRAL

Follow Epigral Ltd into a list and get an email when it puts out news.

Home listing price · NSE:EPIGRAL

₹928.30 INR -16.00 (-1.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:EPIGRAL

Past year -36.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₹925.00 – ₹959.95 INRNov 20, 2026
Volume
44,005 sharesNov 20, 2026
Market cap
₹40.05B INRAt the close on Nov 20, 2026 · price × 43.14M shares outstanding
52-week range
₹807.00 – ₹1,535.20 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₹56.83M INRMedian day 33,098 shares · 3 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Epigral Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NSE:EPIGRAL · Home₹928.30 INR-16.00 (-1.7%)44,005₹945.15₹959.95₹925.00₹944.30Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:EPIGRAL · INR, adjusted for splits

DayCloseChange%OpenHighLowVolume
₹928.30-16.00-1.7%₹945.15₹959.95₹925.0044,005
₹944.30-3.30-0.3%₹947.20₹949.00₹927.2512,154
₹947.60-1.45-0.2%₹944.35₹961.05₹937.5024,781
₹949.05-1.65-0.2%₹948.10₹950.00₹935.0017,711
₹950.70+15.30+1.6%₹941.00₹954.40₹925.0530,255
₹935.40-5.45-0.6%₹945.55₹957.60₹930.0531,474
₹940.85+50.60+5.7%₹900.80₹962.75₹900.8074,301
₹890.25-22.95-2.5%₹923.00₹924.65₹885.0074,703
₹913.20-30.75-3.3%₹936.90₹936.90₹889.3054,044
₹943.95+23.75+2.6%₹942.00₹948.90₹935.3524,866
₹920.20+7.40+0.8%₹915.00₹926.95₹905.0019,145
₹912.80-38.70-4.1%₹955.70₹956.25₹904.1076,825
₹951.50+77.00+8.8%₹879.85₹957.80₹873.60507,810
₹874.50-32.80-3.6%₹916.00₹916.00₹871.0035,846
₹907.30+4.90+0.5%₹905.60₹919.00₹891.1017,700
₹902.40+5.50+0.6%₹903.00₹924.00₹883.8020,438
₹896.90+11.40+1.3%₹887.90₹903.90₹882.2022,567
₹885.50-9.50-1.1%₹897.40₹902.40₹873.0043,240
₹895.00-26.20-2.8%₹923.70₹923.70₹885.0042,724
₹921.20-18.80-2.0%₹937.40₹955.00₹908.0026,699
₹940.00-40.90-4.2%₹980.00₹981.40₹935.6039,572
₹980.90-14.90-1.5%₹996.70₹1,015.00₹961.0068,988
₹995.80+21.40+2.2%₹974.40₹999.50₹970.1021,658
₹974.40-25.40-2.5%₹1,004.50₹1,004.50₹971.1023,701
₹999.80+8.90+0.9%₹989.90₹1,008.90₹980.5024,671
₹990.90+11.60+1.2%₹986.30₹998.70₹966.0033,040
₹979.30-17.10-1.7%₹1,005.00₹1,014.80₹970.8067,198
₹996.40-15.80-1.6%₹1,012.20₹1,017.90₹988.6019,953
₹1,012.20-17.80-1.7%₹1,038.40₹1,038.40₹995.2029,610
₹1,030.00-6.20-0.6%₹1,035.90₹1,040.00₹1,018.3047,054
₹1,036.20+18.90+1.9%₹1,007.40₹1,062.00₹1,005.8067,127
₹1,017.30+35.10+3.6%₹990.00₹1,024.10₹977.4060,534
₹982.200.000.0%₹982.20₹982.20₹982.200
₹982.20-30.30-3.0%₹1,016.20₹1,017.90₹975.9080,328
₹1,012.50-5.60-0.6%₹1,024.00₹1,030.00₹1,011.0037,182
₹1,018.10-19.90-1.9%₹1,045.00₹1,052.40₹1,013.1035,053
₹1,038.00-22.60-2.1%₹1,067.80₹1,068.90₹1,029.3028,476
₹1,060.60-10.40-1.0%₹1,078.50₹1,080.20₹1,051.0033,156
₹1,071.00-22.60-2.1%₹1,091.00₹1,099.00₹1,065.0032,669
₹1,093.60-7.30-0.7%₹1,105.90₹1,114.90₹1,084.2027,575
₹1,100.90-10.10-0.9%₹1,115.00₹1,125.00₹1,095.2022,809
₹1,111.00+5.70+0.5%₹1,109.80₹1,124.90₹1,095.1023,879
₹1,105.30+3.90+0.4%₹1,101.90₹1,119.40₹1,093.1025,007
₹1,101.40+17.40+1.6%₹1,084.00₹1,115.90₹1,077.0023,453
₹1,084.00-8.20-0.8%₹1,092.20₹1,092.20₹1,054.1021,627
₹1,092.20-38.90-3.4%₹1,134.80₹1,136.60₹1,076.7049,513
₹1,131.100.000.0%₹1,131.10₹1,131.10₹1,131.100
₹1,131.10-18.70-1.6%₹1,155.90₹1,155.90₹1,117.0022,425
₹1,149.80-14.10-1.2%₹1,166.10₹1,175.00₹1,140.0035,996
₹1,163.90-25.90-2.2%₹1,185.80₹1,189.80₹1,160.0032,831
₹1,189.80-29.90-2.5%₹1,215.00₹1,215.00₹1,172.4030,444
₹1,219.700.000.0%₹1,219.70₹1,219.70₹1,219.700
₹1,219.70-17.00-1.4%₹1,230.00₹1,254.80₹1,214.5048,188
₹1,236.70+6.10+0.5%₹1,236.80₹1,254.80₹1,221.2039,179
₹1,230.60-8.90-0.7%₹1,235.00₹1,240.80₹1,206.2035,163
₹1,239.50+36.20+3.0%₹1,208.60₹1,252.90₹1,198.6066,587
₹1,203.30-29.50-2.4%₹1,216.20₹1,234.80₹1,196.6042,877
₹1,232.80+26.40+2.2%₹1,206.40₹1,241.00₹1,204.0051,366
₹1,206.40-42.80-3.4%₹1,250.00₹1,264.80₹1,200.3064,607
₹1,249.20+8.30+0.7%₹1,240.80₹1,255.00₹1,232.3056,086
₹1,240.90+38.20+3.2%₹1,212.00₹1,248.00₹1,203.10144,103
₹1,202.70+76.70+6.8%₹1,131.60₹1,228.30₹1,125.60360,212
₹1,126.00+5.50+0.5%₹1,129.50₹1,135.00₹1,108.6029,039
₹1,120.50+38.30+3.5%₹1,087.00₹1,159.00₹1,087.00240,958
Ticker
BSE:EPIGRAL
Asset type
Stock
Sector
Chemicals & materials
Industry
Chemicals
Exchange
BSE
Currency
INR

What changed lately

Latest news

All Epigral Ltd news

Epigral Ltd on 6ix

Sector
Chemicals & materials
Industry
Chemicals
News releases
5 in the last 12 months · 28 in all · newest Nov 2, 2026 · oldest 2021
Calls
2 calls with a replay · 2 with a transcript · latest Nov 2, 2026
Decks
34 decks · latest Nov 2, 2026

Where Epigral Ltd is listed

ListingExchangeCountryCurrency
NSE:EPIGRAL · Home listingNSEIndiaINR
BSE:EPIGRAL · This pageBSEIndiaINR

Valuation

P/E 14.1× against a median of 99.2×: 2nd lowest of 7 Chemicals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
₹44.75B INR
P/E
14.1×
EV/sales
1.6×
EV/EBITDA
7.6×
Price/book
1.7×
Gross margin
24.1%
Operating margin
14.9%
Net margin
10.2%
Debt to equity
0.2×
Beta
No index for this market yet

Chemicals: the 10 companies nearest in size, of 628 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Epigral Ltd · NSE:EPIGRALUS$432.2MUS$482.9M14.1×1.6×7.6×1.7×10.2%0.2×n/a
Kangda New Materials (Group) Co. Ltd. Class A · SZSE:002669US$443.9MUS$470.0M28.5×0.6×n/a1.1×1.8%0.3×n/a
Jiangsu Feymer Technology Co., Ltd. Class A · SSE:688350US$443.0MUS$437.1Mn/a2.1×n/a1.6×−2.0%0.3×n/a
GHCL Limited · NSE:GHCLUS$442.6MUS$335.8M7.6×1.0×4.3×1.1×17.3%0.0×n/a
Shanghai Kinlita Chemical Co., Ltd. Class A · SZSE:300225US$441.5MUS$386.3M170×2.8×n/a3.4×1.9%0.0×n/a
Everlight Chemical Industrial Corporation · TWSE:1711US$439.2MUS$492.7M199×2.1×27.7×1.6×0.9%0.4×n/a
Shanghai Yongguan Adhesive Products Corp., Ltd. Class A · SSE:603681US$435.1MUS$348.0M21.4×0.3×n/a0.8×1.9%0.1×n/a
Yingkou Fengguang Advanced Material Co. Ltd. Class A · SZSE:301100US$434.9MUS$357.9Mn/a2.2×n/a1.4×−2.1%0.0×n/a
Jiangsu Yida Chemical Co. Ltd. Class A · SZSE:300721US$429.6MUS$415.8Mn/a1.3×n/a2.6×−0.2%0.0×n/a
Valhi, Inc. · NYSE:VHIUS$428.5MUS$764.2M330×0.3×3.7×0.4×0.1%0.5×0.66
Chemplast Sanmar Limited · NSE:CHEMPLASTSUS$426.6MUS$557.5Mn/a1.1×52.6×2.5×−7.6%1.1×n/a
Median of the othersUS$437.2MUS$426.5M99.2×1.2×16.0×1.5×0.5%0.3×0.66

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
1728.00 INR · Analysts' mean
EPS, year to Mar 2027
80.35 · 2 analysts
Revenue, year to Mar 2027
30.88B · 2 analysts

Team and board

Officers

OfficerRole
Kaushal SoparkarExecutive Director
Maulik PatelChairman & Managing Director

Board

DirectorRole
Ankit PatelNon-Executive Director
Darshan PatelNon-Executive Director
Kanu PatelIndependent Director
Karana PatelNon-Executive Director
Kaushal SoparkarExecutive Director
Manu PatelIndependent Director
Priyanka ChopraIndependent Director
Raju SwamyIndependent Director
Sanjay AsherIndependent Director

Events

Calls

CallWhenStatus
Epigral (NSE:EPIGRAL) Q2 2027 Earnings CallMon, Nov 02, 2026 · 12:36 PM ETReplay
Epigral (NSE:EPIGRAL) Q1 2027 Earnings CallMon, Jul 27, 2026 · 12:55 PM ETReplay

Results days

QuarterResultsShare move
Q4 2026May 2, 2026 · Before open+9.3%
Q2 2026Nov 10, 2025 · Before open−7.3%
Q1 2026Aug 2, 2025 · Before open−6.5%
Q4 2025May 5, 2025 · Before open+0.9%
Q3 2025Jan 27, 2025 · Before open+5.7%
Q2 2023Oct 20, 2022 · Before open−5.4%

Open Events

Decks

DeckKindSlidesDate
Q2 FY2027 Earnings PresentationEarnings42 slidesNov 2, 2026
Q1 FY2027 Earnings PresentationEarnings38 slidesJul 27, 2026
Q4 FY2026 Earnings PresentationEarnings39 slidesMay 2, 2026
Q3 FY2026 Earnings PresentationEarnings39 slidesJan 30, 2026
Q2 FY2026 Earnings PresentationEarnings39 slidesNov 10, 2025
Q1 FY2026 Earnings PresentationEarnings37 slidesAug 2, 2025
Q4 FY2025 Earnings PresentationEarnings40 slidesMay 5, 2025
Q3 FY2025 Earnings PresentationEarnings41 slidesJan 27, 2025
Q2 FY2025 Earnings PresentationEarnings41 slidesNov 9, 2024
Q1 FY2025 Earnings PresentationEarnings36 slidesJul 24, 2024
All 34 decks
DeckKindSlidesDate
Q4 FY2024 Earnings PresentationEarnings19 slidesApr 22, 2024
Investor Presentation (April 2024)Investor deck24 slidesApril 2024
Q3 FY2024 Earnings PresentationEarnings18 slidesJan 24, 2024
Q2 FY2024 Earnings PresentationEarnings18 slidesNov 6, 2023
Investor Presentation (September 2023)Investor deck26 slidesSep 29, 2023
Investor Presentation (August 2023)Investor deck25 slidesAug 16, 2023
Q1 FY2024 Earnings PresentationEarnings17 slidesAug 5, 2023
Meghmani Finechem — Investor Presentation (May 2023)Investor deck26 slidesMay 4, 2023
Meghmani Finechem — Q4 FY2023 Earnings PresentationEarnings18 slidesApr 25, 2023
Meghmani Finechem — Q3 FY2023 Earnings PresentationEarnings27 slidesJan 24, 2023
Meghmani Finechem — Q3 FY2023 Earnings PresentationEarnings19 slidesJan 19, 2023
Meghmani Finechem — Q2 FY2023 Earnings PresentationEarnings20 slidesOct 20, 2022
Meghmani Finechem — Investor Presentation (August 2022)Investor deck27 slidesAug 8, 2022
Meghmani Finechem — Q1 FY2023 Earnings PresentationEarnings18 slidesJul 21, 2022
Meghmani Finechem — Investor Presentation (June 2022)Investor deck28 slidesJun 7, 2022
Meghmani Finechem — FY2022 Earnings PresentationEarnings28 slidesApr 28, 2022
Meghmani Finechem — Q4 FY2022 Earnings PresentationEarnings23 slidesApr 25, 2022
Meghmani Finechem — Q3 FY2022 Earnings PresentationEarnings21 slidesJan 24, 2022
Meghmani Finechem — Investor Presentation (November 2021)Investor deck28 slidesNov 16, 2021
Meghmani Finechem — Investor Presentation (November 2021)Investor deck28 slidesNov 15, 2021
Meghmani Finechem — Corporate Update (November 2021)Corporate update9 slidesNov 11, 2021
Meghmani Finechem — Q2 FY2022 Earnings PresentationEarnings20 slidesOct 26, 2021
Meghmani Finechem — Investor Presentation (August 2021)Investor deck25 slidesAug 20, 2021
Meghmani Finechem — Q1 FY2022 Earnings PresentationEarnings18 slidesAug 18, 2021

Open Decks

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue25.0B25.5B18.9B21.7B15.5B8.26B6.10B7.10B5.97B3.92B
Cost of revenue20.4B14.8B11.2B15.3B8.01B4.12B2.92B2.69B2.49B1.75B
Gross profit4.63B10.7B7.79B6.43B7.48B4.13B3.18B4.41B3.49B2.17B
Research and development8.60M5.50M9.40M7.62M7.62M5.12M
Selling, general and administrative69.8M50.1M70.0M62.7M47.1M38.5M19.8M18.1M13.6M
Operating income3.82B9.52B3.33B5.68B4.24B1.88B1.54B2.59B3.19B2.02B
Depreciation and amortization1.68B1.33B1.24B1.09B859.1M735.4M443.0M541.0M552.7M554.3M
EBITDA5.50B10.8B4.56B6.77B5.10B2.61B1.98B3.13B3.74B2.57B
Interest expense473.6M532.7M741.4M666.6M478.4M311.0M81.5M253.6M77.4M132.2M
Income before tax3.41B5.41B2.91B5.22B3.83B1.61B1.41B2.42B1.95B750.5M
Income tax87.9M1.83B948.8M1.69B1.31B600.2M290.0M594.8M396.9M85.1M
Net income3.32B3.58B1.96B3.53B2.53B1.01B1.12B1.83B1.55B665.4M
Earnings per share, basic76.9584.6847.1485.0360.8417.2619.2944.0037.429.40

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents54.6M186.4M31.8M142.4M250.9M6.80M969.0K1.29B731.0K856.0K
Short-term investments82.2M778.6M85.3M191.1M18.8M764.3M285.3M
Receivables4.17B2.32B1.79B1.79B2.58B1.20B762.0M792.3M768.6M443.9M
Inventory3.49B3.88B2.63B2.12B1.54B539.6M480.4M406.5M296.0M281.5M
Current assets8.27B7.75B5.02B4.19B4.47B1.81B1.32B2.54B1.87B1.11B
Total assets35.1B31.5B27.9B24.3B21.2B14.5B12.7B10.4B6.71B5.28B
Accounts payable2.60B1.86B1.65B1.10B1.10B730.5M467.9M363.4M331.5M184.1M
Current liabilities7.10B4.93B7.80B6.48B5.32B3.89B2.65B1.77B1.52B1.21B
Long-term debt3.34B4.49B4.92B4.35B5.57B
Total debt5.72B5.93B9.64B8.79B9.93B5.42B5.31B3.90B742.8M1.24B
Total liabilities12.8B12.5B15.4B13.6B14.0B7.65B6.90B5.51B1.54B1.66B
Shareholders' equity22.2B19.0B12.5B10.7B7.26B6.84B5.83B4.93B5.17B3.62B
Shares outstanding43.1M42.2M41.6M41.6M41.6M58.4M58.1M41.6M41.6M70.8M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations3.88B4.41B3.98B6.26B2.84B2.29B1.65B2.61B2.25B1.38B
Capital spending-3.94B-1.95B-3.98B-4.16B-4.56B-1.97B-3.69B-3.03B-1.23B-349.3M
Free cash flow-65.3M2.46B-7.90M2.10B-1.72B324.2M-2.05B-412.9M1.01B1.04B
Cash from investing-3.55B-2.62B-4.01B-4.37B-4.55B-1.97B-3.63B-2.17B-1.67B-628.9M
Cash from financing-457.9M-1.64B-76.0M-2.00B1.95B-319.0M694.1M850.9M-583.2M-760.5M
Dividends paid-183.2M-418.6M-251.2M-242.2M-168.7M-153.6M
Share buybacks0-950.0M-550.0M-609.2M0-2.22B
Change in cash-167.3M154.6M-110.6M-108.5M244.1M5.83M-1.29B1.29B-125.0K-4.80M

Open Financials

Filings

FilingDateTypeFiled with
Epigral Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "UNAUDITED FINANCIAL RESULTS - Q2 FY27".Nov 2, 2026ResultsNSE India
Epigral Ltd Press Release Jul 27 2026Jul 27, 2026ResultsNSE India
Press Release May 02 2026May 2, 2026ResultsNSE India
Press Release Feb 03 2026Feb 3, 2026Other filingsNSE India
Press Release Jan 30 2026Jan 30, 2026ResultsNSE India
Press Release Nov 10 2025Nov 10, 2025Other filingsNSE India
Press Release Aug 02 2025Aug 2, 2025ResultsNSE India
Press Release May 05 2025May 5, 2025ResultsNSE India
Press Release Jan 27 2025Jan 27, 2025ResultsNSE India
Press Release Nov 09 2024Nov 9, 2024ResultsNSE India
All 28 filings
FilingDateTypeFiled with
Press Release Jul 24 2024Jul 24, 2024ResultsNSE India
Press Release Apr 22 2024Apr 22, 2024ResultsNSE India
Press Release Apr 03 2024Apr 3, 2024Other filingsNSE India
Press Release Jan 24 2024Jan 24, 2024Other filingsNSE India
Press Release Nov 20 2023Nov 20, 2023Operations updateNSE India
Press Release Nov 06 2023Nov 6, 2023ResultsNSE India
Press Release Aug 06 2023Aug 6, 2023ResultsNSE India
Press Release Apr 25 2023Apr 25, 2023Other filingsNSE India
Press Release Jan 19 2023Jan 19, 2023Other filingsNSE India
Press Release Oct 20 2022Oct 20, 2022Other filingsNSE India
Press Release Jul 21 2022Jul 21, 2022Other filingsNSE India
Press Release Jun 01 2022Jun 1, 2022Other filingsNSE India
Press Release May 28 2022May 28, 2022Other filingsNSE India
Press Release Apr 25 2022Apr 25, 2022Other filingsNSE India
Press Release Jan 24 2022Jan 24, 2022Other filingsNSE India
Press Release Nov 11 2021Nov 11, 2021Other filingsNSE India
Press Release Oct 26 2021Oct 26, 2021Other filingsNSE India
Press Release Aug 18 2021Aug 18, 2021Other filingsNSE India

Open Filings

Cap table

Built by 6ix from Epigral Ltd’s releases

Common shares
43,141,338
Fully diluted
43,141,338

Fully diluted

LineShares
Common shares43,141,338

Share count over time

CountShares
Nov 22, 202643,141,338

Open Cap table

Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ankit PatelNon-Executive Director · Since at least Nov 4, 2026
Darshan PatelNon-Executive Director · Since at least Nov 4, 2026
Kanu PatelIndependent Director · Since at least Nov 6, 2026
Karana PatelNon-Executive Director · Since at least Nov 4, 2026
Kaushal SoparkarExecutive Director · Since at least Nov 6, 2026
Manu PatelIndependent Director · Since at least Nov 6, 2026
Maulik PatelChairman & Managing Director · Since at least Nov 6, 2026
Priyanka ChopraIndependent Director · Since at least Nov 6, 2026
Raju SwamyIndependent Director · Since at least Nov 6, 2026
Sanjay AsherIndependent Director · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Epigral Ltd.